Navigation Links
Fas in Medical News

The Ensign Group Reports Second Quarter 2009 Earnings of $0.39 per Share; Reaffirms 2009 EPS Guidance

...se of $3.8 million. Fully diluted GAAP earnings per share were $0.39 for the quarter, compared to $0.32 per share in the prior year. Excluding fas 141R acquisition expenses and amortization of patient bases, adjusted net income was $8.3 million or $0.40 per diluted share. When acquiring existing ...

Rochester Medical Reports Third Quarter Results

...djustments for recurring non-cash expenses: Intangible amortization (2) 129,000 129,000 386,000 386,000 fas 123R compensation expense (3) 193,000 195,000 683,000 713,000 ------- ------- ...

Palomar Medical Reports Financial Results for Second Quarter 2009

... the second quarter ended June 30, 2009 was $0.3 million, which included approximately $0.2 million in litigation expenses and a $0.8 million non-cash fas 123R stock-based compensation expense. The Company reported net loss of $0.2 million, or $0.01 per diluted share for the second quarter of 2009. The...

WellPoint Reports Second Quarter 2009 Results

...ent period presentation. The Company adopted FASB Staff Position No. fas 115-2 and fas 124-2 (the "FSP") on April 1, 2009. The FSP provides new guidance on the r...

Critical link in cell death pathway revealed

...said. "One of the things that's very curious about fas is that, depending on the cell type, the way the k...immune response), the killing is very direct. When fas is activated a protein-destroying enzyme called ca...as in several chronic liver diseases activation of fas is thought to contribute to cell destruction, he s...

Gene's novel role may provide key to treating liver and neurodegenerative diseases

...s elucidated part of the sequence of molecular events that regulates Fas-mediated apoptosis. They found that FAIM functioned as a key switch in the fas cell death circuit, which could be turned up or down to prolong or decrease cell survival. Therefore, in principle, this gene could make a good ta...

Escalon(R) Reports Third Quarter Fiscal 2009 Results

...he Company's current financial performance and provide further information for comparative purposes due to the adoption of the new accounting standard fas 123R. Specifically, the Company believes the non-GAAP measures provide useful information to both management and investors by isolating certain e...

AMN Healthcare Announces First Quarter 2009 Results

...nts related to workforce reductions as well as lease-related charges associated with facility consolidations. Also, in accordance with accounting rule fas 142, the company incurred $176 million in non-cash impairment charges relating to goodwill and certain other intangible assets resulting from a combin...

The Ensign Group Reports First Quarter 2009 Earnings of $0.38 per Share; Reaffirms 2009 Guidance

...ortion of this release. Fully diluted net earnings per share was $0.38 for the quarter, compared to $0.31 per share in the prior year. Excluding fas 141R acquisition expenses and amortization of patient bases, adjusted net income was $8.1 million or $0.39 per diluted share. When acquiring existing ...

IPC The Hospitalist Company Reports Record First Quarter 2009 Results

...eased general and administrative expenses as a result of the requirement of fas Statement 141(R) to expense external costs associated with acquisitions tha...d to acquisitions that close subsequent to December 31, 2008 as required by fas Statement 141(R). Conference Call Information IPC The Hospitalis...

Rochester Medical Reports Second Quarter Results

...ents for recurring non-cash expenses: Intangible amortization (2) 129,000 129,000 258,000 258,000 fas 123R compensation expense (3) 354,000 391,000 567,000 600,000 ------- ...

Torchmark Corporation Reports First Quarter 2009 Results

... In April 2009, the FASB issued Staff Positions fas 157-4, fas 115-2 and fas 124-2, and...

Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status

...umstances may cause the Company to consume capital significantly faster or slower than currently anticipated. On January 1, 2006, Alexza adopted fas 123R and reports employee share-based compensation expense based on the grant date fair value of the award. Share-based compensation was $1.6 million...

Medarex Announces 2008 Fourth Quarter and Year End Financial Results

...ock-based compensation recorded in accordance with fas 123(R); and a non-cash impairment charge of $5.3 m...d compensation expense recorded in accordance with fas 123(R) and approximately $1.5 million related to C...d compensation expense recorded in accordance with fas 123(R) and approximately $1.7 million related to C...

Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results

...loyee stock-based compensation under fas 123R (4) 4,987 3,861 18,7...loyee stock-based compensation under fas 123R (4) 0.08 0.07 0..... (4) Employee stock-based compensation under fas 123R: Our management excludes the effects ...

Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results

...loyee stock-based compensation under fas 123R (4) 4,987 3,861 18,7...loyee stock-based compensation under fas 123R (4) 0.08 0.07 0..... (4) Employee stock-based compensation under fas 123R: Our management excludes the effects ...

Escalon(R) Reports Second Quarter Fiscal 2009 Results

...he Company's current financial performance and provide further information for comparative purposes due to the adoption of the new accounting standard fas 123R. Specifically, the Company believes the non-GAAP measures provide useful information to both management and investors by isolating certain e...

Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008

...in litigation expenses and a $0.8 million non-cash fas 123R stock-based compensation expense. Revenu...in litigation expenses and a $5.9 million non-cash fas 123R stock-based compensation expense. The Co... 2008, which includes adjustments for the non-cash fas 123R compensation expense and non-cash taxes, resu...

Rochester Medical Reports First Quarter Results

... == ===== Adjustments for recurring non-cash expenses: Intangible Amortization (1) 163,000 163,000 fas 123R Compensation Expense (2) 265,000 251,000 ------- ------- Subtotal ...

FASgen, Inc. Announces Research and License Agreement With Centocor, Inc.

... researchers have extensive experience studying the over-expression of FAS, an enzyme over-expressed in virtually all solid tumors. The inhibition of fas causes tumor cell apoptosis and holds promise for new therapeutic treatments for cancer. The economic terms of the research collaboration were n...

Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results

...,465) Non-GAAP adjustments: Employee stock-based compensation under fas 123R 4,340 3,641 13,809 10,266 ...0.45) Non-GAAP adjustments: Employee stock-based compensation under fas 123R 0.08 0.07 0.24 0.21 Non-GAAP dilu...

Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates

...fforts, increased personnel-related costs to support these efforts, and increased share-based compensation costs. On January 1, 2006, Alexza adopted fas 123R and reports employee share-based compensation expense based on the fair value of the award. Share-based compensation was $1,183,000 and $3,821,00...

Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales

...9,000) Adjustments for recurring non-cash expenses: Intangible Amortization (3) 164,000 167,000 653,000 668,000 fas 123R Compensation Expense (4) 283,000 311,000 1,364,000 2,117,000 Subtotal 447,000 478,000 2,017...

Palomar Medical Reports Financial Results for Third Quarter 2008

...in litigation expenses and a $1.2 million non-cash fas 123R stock-based compensation expense. The Compa... 2008, which includes adjustments for the non-cash fas 123R compensation expense and non-cash taxes, resu...ty revenues, legal expense reimbursement, non-cash fas 123R compensation expense, interest on back-owed r...

Existing anti-obesity drugs may be effective against flu, hepatitis and HIV

...vestigate whether this requirement extended to other enveloped viruses, the team measured influenza A replication in the presence of the same TOFA and fas inhibitors, and found similar reductions in replication. Influenza A has little in common with HCMV except for its lipid envelope. Extensive clinic...

Also in the July 29 JNCI

...avidson@mdanderson.org , (713) 794-1731 Modified Salmonella Slows Tumor Growth Attenuated Salmonella bacteria engineered to express the fas ligand (FasL) accumulate in tumors and reduce their growth. Salmonella typhimurium concentrates in tumors following intravenous injection in mice...

HIV conquers immune system faster than previously realized

...of the virus's destructive path. The four byproducts of CD4 T cell death include TRAIL (tumor necrosis factor-related apoptosis-inducing ligand), fas ligand, TNF receptor type 2 and plasma microparticles, tiny bits of cell membrane that are broken up and left floating around in the plasma when the c...

Woman aquires new accent after stroke

...diphthongs ("greasy" was pronounced "gracey", and "dog" was pronounced to rhyme with "rogue".) Humphreys says the research makes her wonder whether fas might be under-reported because doctors rely on family members to alert them to speech changes post-stroke. ...

Medarex Announces 2008 First Quarter Financial Results

...ock-based compensation recorded in accordance with fas 123(R). Excluding the impact of these items, Medar...were recorded in accordance with the provisions of fas 123(R). fas 123(R) requires companies to record stock-based pa...

DRAXIS Health Reports Results for the First Quarter of 2008

...ary 1, 2008, the Company adopted SFAS # 157, "Fair Value Measurements" ("SFAS 157"). In February 2008, the FASB issued FASB Staff Position # fas 157-2, "Effective Date of FASB Statement # 157", which provides a one year deferral of the effective date of SFAS 157 for non-financial asse...

Smart Balance Announces 2008 First-Quarter Results

...no impact on full year results. In accordance with fas No. 154, a retrospective application of the change...0 Non-cash charges affecting Operating Income: fas 123R Stock Option Expense ... Non-cash charges after-tax affecting Net Loss: fas 123R Stock Option Expense ...

FASgen Diagnostic Tests Identify Ovarian Cancer Progression and Apoptosis

...n evaluating 321 samples of serous ovarian cancer. fas expression correlated with high grade disease and ...ed to 60.4 months for low expressors. Furthermore, fas levels were highest in recurrent tumors. This is s...ncer. The FAS-detect(TM) ELISA was used to measure fas levels in ovarian cancer ascites in 117 advanced s...

Medarex Announces 2007 Fourth Quarter and Year End Financial Results

...ock based compensation recorded in accordance with fas 123(R), an acquisition of in-process technology ch...d compensation expense recorded in accordance with fas 123(R), and (iii) approximately $2.7 million of in...were recorded in accordance with the provisions of fas 123(R)....

KV Pharmaceutical Company Completes Unaudited Fiscal 2007 Results; Receives Trading Extension From NYSE

...outstanding awards that are not expected to vest as of the adoption of fas 123R. K-V PHARMACEUTICAL COMPANY AND SUBSIDIARIES UN...outstanding awards that are not expected to vest as of the adoption of fas 123R. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) ...

NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance

...ompensation due to the varying valuation methodologies, subjective assumptions and the variety of types of awards that companies can use when applying fas 123R along with the fact that a substantial portion of our outstanding options and restricted stock units are held by our independent contractor physi...

Debut issue of Foot & Ankle Specialist

...new journal will enable practitioners to address a broad range of disorders and provide their patients with the best current diagnosis and therapy. fas is edited by Bob Baravarian, DPM, chief of foot and ankle surgery at Santa Monica/UCLA Medical Center and Orthopedic Hospital, assistant clinical prof...

Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year

...2006 were computed according to the provisions of fas 123R. (2) Includes charges of $(9,143)K recorde...eporting unit in September 2006 in accordance with fas 142, "Goodwill and Other Intangible Assets."...86 Acquisition Amortization fas 123R Effect of GAAP Relat...

Eye Blinks May ID Fetal Alcohol Exposure

...of the journal Alcoholism: Clinical & Experimental Research . "This study clearly links one brain area to the learning deficits experienced by fas children, whether or not they have physical manifestations of the condition, and thus can provide a basis for the development of remediation programs,...

Rochester Medical Reports Record Fourth Quarter Sales and Record Year

...9,000) Adjustments for recurring non-cash expenses: Intangible Amortization (4) 167,000 188,000 668,000 218,000 fas 123R Compensation Expense (5) 311,000 95,000 2,117,000 600,000 Subtotal 478,000 283,000 2,78...

Escalon(R) Reports First Quarter Fiscal 2008 Results

...formance and provide further information for comparative purposes due to depreciation and amortization and the adoption of the new accounting standard fas 123R. The non-GAAP measures and the reconciliation to the most directly comparable GAAP measure of all non-GAAP measures are as follows: ...
Other Tags
(Date:12/15/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ) ... Facial Recognition Market 2015-2019" report to their ... Facial recognition is a technology used ... measures the overall facial feature of a person ... distance between eyes. Facial recognition is used for ...
(Date:12/11/2014)... SALEM, N.C. , Dec. 10, 2014  That blood ... for quite a while. Hypertension – the medical term for ... in the early 1800s, and the inflatable cuff that,s used ... That doesn,t, however, mean there,s nothing new about hypertension, its ... some long-held beliefs about the condition and the best ways ...
(Date:12/10/2014)... 9, 2014  Valencell, a leader in performance biometric ... staggering demand from its licensees for highly accurate, clinically ... not solely coming from fitness and health sectors, but ... "A wearable is only as useful as the biometric ... ultimate driver in long-term mass consumer adoption of wearable ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wearable Technology Products Demand Highly Accurate Biometric Technology 2
(Date:12/25/2014)... Recently, iFitDress.com, the popular online supplier of wedding dresses and ... of black one-shoulder cocktail dresses . In addition, all ... at discounted prices, up to 70% off. , ... weeks only. You know, we have thousands of frequent callers ... new items can visit our website for more details. The ...
(Date:12/25/2014)... 25, 2014 BambooFlooringChina.com sells many bamboo ... bamboo flooring. Today, the company announces big discounts ... styles and colors. , BambooFlooringChina.com is the world’s leader ... promotion is valid until Jan. 20, 2015. , The ... woven with a natural thread. All the bamboo strips ...
(Date:12/25/2014)... By Dennis Thompson ... -- Very sick children with complex chronic illnesses can receive ... a "medical home," with easy access to a team of ... were less likely to become seriously ill and need either ... received treatment at an enhanced medical home clinic at the ...
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... closing in on a "fountain of youth" drug that can ... older adults, a new study suggests. Seniors received a ... that targets a genetic signaling pathway linked to aging and ... The experimental medication, a version of the drug ...
(Date:12/25/2014)... Plugin creators from Pixel Film Studios have ... business presentation tool made specifically for Final Cut ... tool, users can now display their stats and facts ... Studios. “ProFire 5k gives users a multiple options to ... a presentation” , Pixel Film Studios takes the heat ...
Breaking Medicine News(10 mins):Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2
Other Contents